Sodium stibogluconate
葡萄糖酸锑钠
Report date: 2026/03/11 20:02:12
NME
Base Information
Drug NameSodium stibogluconate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesGlaxosmithkline PlcInstitute Of Tropical Medicine AntwerpShandong Xinhua Pharmaceutical Company Ltd
Inactive CompaniesAccess to Advanced Health InstituteNational Cancer InstituteNorthwestern University
Active Indications
Inactive Indications